搜索临床试验以:CYP2C19 loss-of-function allele(s) carrier
总计66454个结果
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)完全的
-
University of California, San Francisco终止ALK融合蛋白表达 | III 期皮肤黑色素瘤 | IIIA 期皮肤黑色素瘤 | IIIB 期皮肤黑色素瘤 | IIIC 期皮肤黑色素瘤 | IV 期皮肤黑色素瘤 | ROS1融合阳性 | BRAF 等位基因 | 侵袭性皮肤黑色素瘤 | MET融合基因阳性 | NRAS wt 等位基因 | NTRK1融合阳性 | NTRK2融合阳性 | NTRK3融合阳性 | RET融合阳性美国
-
Jiangsu vcare pharmaceutical technology co., LTD完全的
-
Institut de Recherches Internationales ServierADIR, a Servier Group company完全的
-
Southwest Regional Wound Care CenterSorbion Aktiengesellschaft, Germany完全的
-
Gangnam Severance HospitalYonsei University; Myung In Pharmaceutical Company完全的
-
Organon and CoBayer完全的高胆固醇血症 | 家族性高胆固醇血症 | 纯合谷甾醇血症
-
U.S. Army Medical Research and Development CommandGlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)完全的
-
Fenwal, Inc.Children's Hospital of Philadelphia; Washington University School of Medicine; University of Texas 和其他合作者完全的
-
St. Antonius HospitalJeroen Bosch Ziekenhuis完全的
-
Tamkeen SaleemUniversity of Warwick; University of Leicester; The American Association of Suicidology邀请报名
-
Peking University Cancer Hospital & Institute招聘中
-
AIPING ZHOU尚未招聘免疫疗法 | 信蒂利单抗 | 局部晚期实体瘤 | 奥沙利铂 | HER2阳性 | 胃或胃食管结合部腺癌 | S-1中国
-
Anne Birgitte RabenUniversity of Leeds; Wageningen University; University of Liverpool; Maastricht University; Harokopio... 和其他合作者完全的
-
UOSD Emodinamica Diagnostica e Interventistica未知
-
Federal University of São Paulo完全的
-
Peking UniversityTaiho Pharmaceutical Co., Ltd.未知